Cabaletta Bio, Inc. — Director's Dealing 2021

Jun 28, 2021

SEC Form 4/A — Form 4/A

Issuer: Cabaletta Bio, Inc. (CABA)
CIK: 0001759138
Period of Report: 2021-06-01

Reporting Person: DANIELS BRIAN (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-01	Stock Option (Right to buy)	$11.00	A	22000	Disposed	2031-05-31	Common Stock (22000)	Direct

Footnotes

F1: This option shall vest in accordance with the following schedule: (1) 25% of the shares subject to the option shall vest on June 24, 2022 and (2) the remaining 75% of the shares subject to the option shall vest in equal quarterly installments over the next 3 years, subject to the Reporting Person's continued service relationship with the Issuer.